# Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study.

> **NCT01235273** · PHASE2 · SUSPENDED · sponsor: **Federico II University** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** Growth Hormone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01235273
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2011-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** insufficient enrollment
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235273, "Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01235273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*